In summary, our study using transgenic hERG-HEK293 and human cardiomyocytes indicate that Mitragynine and its analogues may induce potentially fatal TdP by suppressing hERG-mediated K+ currents and prolonging APD. The gene discussed is KCNH2; the disease is torsades de pointes.